Zinc for the common cold

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Singh, Meenu ^a   Das, Rashmi R ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ZINC; DRUG DOSAGE FORM; GLUCONIC ACID; ZINC ACETATE; ZINC DERIVATIVE; ZINC SULFATE;

ABDOMINAL PAIN; COMMON COLD; CONSTIPATION; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; HUMAN; INCIDENCE; LOZENGE; META ANALYSIS; MINERAL SUPPLEMENTATION; MOUTH INFLAMMATION; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TASTE; XEROSTOMIA; DRUG DOSAGE FORM; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEVERITY OF ILLNESS INDEX;

COMMON COLD; DOSAGE FORMS; GLUCONATES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; ZINC; ZINC ACETATE; ZINC COMPOUNDS; ZINC SULFATE;

EID: 84891688261     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD001364.pub4     Document Type: Review

References (63)

1. Al-Nakib W, Higgins PG, Barrow I, Batstone G, Tyrell DAJ. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. Journal of Antimicrobial Chemotherapy 1987;20:893-901.
2. Douglas R, Miles H, Moore B, Ryan P, Pinnock C. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrobial Agents and Chemotherapy 1987;31(8):1263-5.
3. Farr B, Conner E, Betts R, Oleski J, Minnefor A, Gwaltney J. Two randomised controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrobial Agents and Chemotherapy 1987;31(8):1183-7.
4. Godfrey JC, Sloanne BB, Smith D, Turco JH, Mercer N, Godfrey NJ. Zinc gluconate and the common cold: a controlled clinical study. Journal of International Medical Research 1992;20(3):234-46.
5. Kurugol Z, Akilli M, Bayram N, Koturoglu G. The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children. Acta Paediatrica 2006;95:1175-81.
6. Kurugol Z, Akilli M, Bayram N, Koturoglu G. The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children. Acta Paediatrica 2006;95:1175-81.
7. Kurugol Z, Bayram N, Atik T. Effect of zinc sulfate on common cold in children: randomized, double blind study. Pediatrics International 2007;49:842-7.
8. Macknin ML, Piedmonte M, Calendine C, Janosky J, Wald E. Zinc gluconate lozenges for treating the common cold in children. JAMA 1998;279(24):1962-7.
9. Mossad SB, Macknin M, Medendorp S. Zinc gluconate lozenges for treating the common cold. Annals of Internal Medicine 1996;125(2):81-8.
10. Petrus EJ, Lawson KA, Bucci LR, Blum K. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Current Therapeutic Research 1998;59(9):595-607.
11. Prasad AS, Fitzgerald JT, Bao B, Beck FWJ, Chandrasekar PH. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. Annals of Internal Medicine 2000;133(4):245-52.
12. Prasad AS, Beck FWJ, Bao B, Snell D, Fitzgerald JT. Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. Journal of Infectious Diseases 2008;197(15):795-802.
13. Smith DS, Helner EC, Nutall CE, Collins M, Rofman B, Ginsberg D, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrobial Agents and Chemotherapy 1989;33(5):646-8.
14. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clinical Infectious Diseases 2000;31:1202-8.
15. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clinical Infectious Diseases 2000;31:1202-8.
16. Turner RB, Cetnarowski WE. Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds. Clinical Infectious Diseases 2000;31:1202-8.
17. Vakili R, Vahedian M, Khodaei GH, Mahmoudi M. Effects of zinc supplementation in occurrence and duration of common cold in school aged children during cold season: a double-blind placebo-controlled trial. Iranian Journal of Pediatrics 2009;19(4):376-80.
18. Weismann K, Jakobsen J, Weismann JE, Hammer UM, Nyholm SM, Hansen B, et al. Zinc gluconate lozenges for common cold. Danish Medical Journal 1990;37:279-81.
19. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double blind study. Antimicrobial Agents and Chemotherapy 1984;25:20-4.
20. Eby GA, Halcomb WW. Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: a double-blind, placebo-controlled clinical trial. Alternative Therapies In Health And Medicine 2006;12(1):34-8.
21. Kartasurya MI, Ahmed F, Subagio HW, Rahfiludin MZ, Marks GC. Zinc combined with vitamin A reduces upper respiratory tract infection morbidity in a randomised trial in preschool children in Indonesia. British Journal of Nutrition 2012;108(12):2251-60.
22. McElroy BH, Miller SP. An open-label, single-center, phase IV clinical study of the effectiveness of zinc gluconate glycine lozenges (Cold-Eeze) in reducing the duration and symptoms of the common cold in school-aged subjects. American Journal of Therapeutics 2003;10:324-9.
23. Potter YJ, Hart LL. Zinc lozenges for the common cold. Annals of Pharmacotherapy 1993;27:589-91.
24. Veverka DV, Wilson C, Martinez MA, Wenger R, Tamosuinas A. Use of zinc supplements to reduce upper respiratory infections in United States Air Force Academy Cadets. Complementary Therapies in Clinical Practice 2009;15:91-5.
25. Caruso TJ, Prober CG, Gwaltney JM. Treatment of naturally acquired common colds with zinc: a structured review. Clinical Infectious Diseases 2007;45(5):569-74.
26. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA 1984;252:1443-6.
27. Couch RB. The common cold control?. Journal of Infectious Diseases 1984;150:167-73.
28. Eby GA. Linearity in dose-response from zinc lozenges in treatment of common colds. Journal of Pharmacy Technology 1995;11:110-12.
29. Eby GA. Zinc lozenges: cold cure or candy? Solution chemistry determinations. Bioscience Reports 2004;24:23-39.
30. Eby GA 3rd. Zinc lozenges as cure for the common cold - a review and hypothesis. Medical Hypotheses 2010;74(3):482-92.
31. Eby G. The mouth-nose biologically closed electric circuit in zinc lozenge therapy of common colds as explanation of rapid therapeutic action. Expert Review of Respiratory Medicine 2012;6(3):251-2.
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
33. Farr B, Gwaltney JM. The problems of taste in placebo matching: an evaluation of zinc gluconate for the common cold. Journal of Chronic Disease 1987;40(9):875-9.
34. Farr B, Hayden FG, Gwaltney JM. Letter to the Editor. Antimicrobial Agents and Chemotherapy 1988;32:607.
35. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Archives of Internal Medicine 2003;163(4):487-94.
36. Garibaldi RA. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. American Journal of Medicine 1985;78(6B):32-7.
37. Geist F, Bateman J, Hayden F. In vitro activity of zinc salts against human rhinoviruses. Antimicrobial Agents and Chemotherapy 1987;31:622-4.
38. Gwaltney JM Jr, Hendley JO, Simon G, Jordan WS Jr. Rhinovirus infections in an industrial population. I. The occurrence of illness. New England Journal of Medicine 1966;275:1261-8.
39. Harisch G, Kretschmer M. Some aspects of a non-linear effect of zinc ions on the histamine release from rat peritoneal mast cells. Research Communications in Chemical Pathology and Pharmacology 1987;55:39-48.
40. Hatch B, Berthon G. Metal ion-FTS nonapeptide interactions. A quantitative study of zinc(II)-nonapeptide complexes (thymulin) under physiological conditions and assessment of their biological significance. Inorganica Chimica Acta 1987;136:165-71.
41. Hemilä H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respiratory Medicine Journal 2011;5:51-8.
42. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
43. Higgins J, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Chichester: Wiley-Blackwell, 2011.
44. Hulisz D. Efficacy of zinc against common cold viruses: an overview. Journal of the American Pharmacists Association 2004;44:594-603.
45. Jackson JL, Lesho E, Peterson C. Zinc and the common cold: a meta-analysis revisited. Journal of Nutrition 2000;130(Suppl 5):1512-5.
46. Kelly RW, Abel MH. Copper and zinc inhibit the metabolism of prostaglandin by the human uterus. Biology of Reproduction 1983;28:883-9.
47. Kirkpatrick GL. The common cold. Primary Care 1996;23(4):657-75.
48. Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. Journal of Virology 1976;18:298-306.
49. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Annals of Internal Medicine 1997;127:820-6.
50. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. Copenhagen: Wiley-Blackwell, 2011.
51. Macknin ML. Zinc lozenges for the common cold. Cleveland Clinical Journal of Medicine 1999;66:27-32.
52. Marshall S. Zinc gluconate and the common cold. Review of randomized controlled trials. Canadian Family Physician 1998;44:1037-42.
53. Novick SG, Godfrey JC, Godfrey NJ, Wilder HR. How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. Medical Hypotheses 1996;46:295-302.
54. 2+. Bioassays 1987;6:14-9.
55. Pfeiffer CC, Papaioannou R, Sohler A. Effect of chronic zinc intoxication on copper levels, blood formation and polyamines. Journal of Orthomolecular Psychiatry 1980;9:79-89.
56. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
57. Rothman KJ. Causal inference. Epidemiology Resources, Boston: Chestnut Hill 1988.
58. Science M, Johnstone J, Roth DE, Guyatt G, Loeb M. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. Canadian Medical Association Journal 2012;184(10):E551-61.
59. Simasek M, Blandino DA. Treatment of the common cold. American Family Physician 2007;75(4):515-20.
60. Turner RB. The treatment of rhinovirus infections: progress and potential. Antiviral Research 2001;49:1-4.
61. Zarembo JE, Godfrey JC, Godfrey NJ. Zinc(II) in saliva: determination of concentrations produced by different formulations of zinc gluconate lozenges containing common excipients. Journal of Pharmaceutical Sciences 1992;81(2):128-30.
62. Marshall IIR. Zinc for the common cold. Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: 10.1002/14651858.CD001364.pub3]
63. Singh M, Das RR. Zinc for the common cold. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD001364.pub3]